Postnatal corticosteroids and developmental outcomes in extremely preterm or extremely low birth weight infants: The Victorian Infant Collaborative Study 2016–17 cohort
Acta Paediatrica · 2023
DOI: 10.1111/apa.16696 ↗Kurz gefasst
Kommentar in der Zeitschrift Acta Paediatrica, 2023. Verfasst von Ellen Douglas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Newborn Research Centre, Royal Women's Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Cerebral Palsy, Bronchopulmonary Dysplasia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council of Australia, Emerging Leadership Fellowship, the Medical Research Future Fund of Australia.
Abstract (Originalsprache)
Aim
Systemic postnatal corticosteroids are used to treat or prevent bronchopulmonary dysplasia (BPD) in extremely preterm (EP) or extremely low birth weight (ELBW) infants but are associated with long‐term harm. We aimed to assess the relationship between cumulative postnatal corticosteroid dose and neurodevelopmental outcomes.
Methods
Longitudinal cohort study of all EP/ELBW livebirths in Victoria, Australia 2016–2017. Perinatal data were collected prospectively. Neurodevelopmental assessment was performed at 2 years' corrected age. Linear and logistic regression were used to determine relationships between cumulative corticosteroid dose and neurodevelopment, adjusted for gestational age, birth weight, sex and major intraventricular haemorrhage.
Results
Seventy‐six EP/ELBW infants received postnatal corticosteroids to treat or prevent BPD, 62/65 survivors were seen at 2 years. Median (IQR) cumulative postnatal corticosteroid dose was 1.36 (0.92–3.45) mg/kg dexamethasone equivalent. Higher cumulative corticosteroid dose was associated with increased odds of cerebral palsy, adjusted OR (95% CI) 1.47 (1.04, 2.07). Higher cumulative corticosteroid dose was also associated with lower cognitive and motor developmental scores, however, this weakened after adjustment for confounding variables: cognitive composite score adjusted coefficient (95% CI) −1.3 (−2.7, 0.1) and motor composite score adjusted coefficient (95% CI) −1.3 (−2.8, 0.2).
Conclusion
Higher cumulative postnatal corticosteroid dose in EP/ELBW infants is associated with increased odds of cerebral palsy at 2 years' corrected age. Adequately powered studies are needed to assess the independent effects of cumulative steroid dose on neurodevelopmental outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Newborn Research Centre, Royal Women's Hospital, Melbourne, Victoria, Australia.
- Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Victoria, Australia.
- Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
- Monash Newborn, Monash Children' Hospital, Melbourne, Victoria, Australia.
- Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Victoria, Australia.
- Mercy Hospital for Women, Melbourne, Victoria, Australia.
ORCID-Profile: Kate A Hodgson, Joy E Olsen, Brett J Manley, Calum T Roberts
Förderung
- National Health and Medical Research Council of Australia
- Emerging Leadership Fellowship
- the Medical Research Future Fund of Australia
- Victorian Government's Operational Infrastructure Support Program
Zitieren
APA
Douglas, E., Hodgson, K. A., Olsen, J. E., Manley, B. J., Roberts, C. T., Josev, E., Anderson, P. J., Doyle, L. W., Davis, P. G., Cheong, J. L. Y., & Victorian Infant Collaborative Study Group (2023). Postnatal corticosteroids and developmental outcomes in extremely preterm or extremely low birth weight infants: The Victorian Infant Collaborative Study 2016–17 cohort. Acta Paediatrica. https://doi.org/10.1111/apa.16696
Vancouver
Douglas E, Hodgson KA, Olsen JE, Manley BJ, Roberts CT, Josev E, et al. Postnatal corticosteroids and developmental outcomes in extremely preterm or extremely low birth weight infants: The Victorian Infant Collaborative Study 2016–17 cohort. Acta Paediatrica. 2023. doi:10.1111/apa.16696
BibTeX
@article{Douglas2023,
author = {Douglas, Ellen and Hodgson, Kate A and Olsen, Joy E and Manley, Brett J and Roberts, Calum T and Josev, Elisha and Anderson, Peter J and Doyle, Lex W and Davis, Peter G and Cheong, Jeanie L Y and Victorian Infant Collaborative Study Group, Victorian Infant Collaborative Study Group},
title = {Postnatal corticosteroids and developmental outcomes in extremely preterm or extremely low birth weight infants: The Victorian Infant Collaborative Study 2016–17 cohort},
journal = {Acta Paediatrica},
year = {2023},
doi = {10.1111/apa.16696}
}
EUVIMED